18.14
price down icon9.25%   -1.85
pre-market  プレマーケット:  19.03   0.89   +4.91%
loading
前日終値:
$19.99
開ける:
$19.22
24時間の取引高:
332.71K
Relative Volume:
1.21
時価総額:
$638.33M
収益:
$4.12M
当期純損益:
$-56.68M
株価収益率:
-3.2727
EPS:
-5.5429
ネットキャッシュフロー:
$-51.44M
1週間 パフォーマンス:
-6.54%
1か月 パフォーマンス:
-16.02%
6か月 パフォーマンス:
-33.75%
1年 パフォーマンス:
-39.53%
1日の値動き範囲:
Value
$18.00
$19.57
1週間の範囲:
Value
$17.50
$20.45
52週間の値動き範囲:
Value
$17.50
$32.27

Dianthus Therapeutics Inc Stock (DNTH) Company Profile

Name
名前
Dianthus Therapeutics Inc
Name
セクター
Healthcare (1164)
Name
電話
929-999-4055
Name
住所
7 TIMES SQUARE, NEW YORK
Name
職員
0
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
DNTH's Discussions on Twitter

DNTH を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
DNTH
Dianthus Therapeutics Inc
18.14 638.33M 4.12M -56.68M -51.44M -5.5429
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Dianthus Therapeutics Inc Stock (DNTH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-20 開始されました TD Cowen Buy
2024-10-03 開始されました Oppenheimer Outperform
2024-07-26 開始されました Robert W. Baird Outperform
2024-06-27 開始されました Cantor Fitzgerald Overweight
2024-05-16 開始されました H.C. Wainwright Buy
2024-02-15 開始されました Stifel Buy
2023-12-26 開始されました Jefferies Buy
2023-11-22 開始されました Wedbush Outperform
2023-10-30 開始されました Guggenheim Buy
2023-09-28 開始されました Raymond James Outperform
2022-08-25 ダウングレード Goldman Buy → Neutral
2022-01-06 アップグレード Goldman Neutral → Buy
2021-08-20 再開されました Goldman Neutral
2021-08-03 ダウングレード JP Morgan Overweight → Neutral
2021-07-22 繰り返されました B. Riley Securities Buy
2021-06-29 開始されました Cantor Fitzgerald Overweight
2021-06-15 開始されました BTIG Research Buy
2021-05-18 開始されました B. Riley Securities Buy
2021-01-07 開始されました Mizuho Buy
2020-06-08 アップグレード Goldman Neutral → Buy
2019-03-25 ダウングレード Goldman Buy → Neutral
2019-03-15 開始されました Raymond James Outperform
すべてを表示

Dianthus Therapeutics Inc (DNTH) 最新ニュース

pulisher
Mar 31, 2025

Swiss National Bank Sells 2,900 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World

Mar 31, 2025
pulisher
Mar 30, 2025

Dianthus Therapeutics (NASDAQ:DNTH) Trading 6.5% HigherHere's Why - MarketBeat

Mar 30, 2025
pulisher
Mar 30, 2025

Dianthus Therapeutics (NASDAQ:DNTH) Reaches New 52-Week LowWhat's Next? - MarketBeat

Mar 30, 2025
pulisher
Mar 27, 2025

Charles Schwab Investment Management Inc. Acquires 1,092 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World

Mar 27, 2025
pulisher
Mar 24, 2025

Deep Track Capital, LP Acquires Significant Stake in Dianthus Th - GuruFocus

Mar 24, 2025
pulisher
Mar 22, 2025

Dianthus Therapeutics (NASDAQ:DNTH) Stock Price Down 3.8%Here's What Happened - MarketBeat

Mar 22, 2025
pulisher
Mar 21, 2025

Avidity Partners Management LP Increases Stake in Dianthus Thera - GuruFocus

Mar 21, 2025
pulisher
Mar 21, 2025

Cantor Fitzgerald Issues Positive Estimate for DNTH Earnings - MarketBeat

Mar 21, 2025
pulisher
Mar 19, 2025

HC Wainwright Brokers Raise Earnings Estimates for DNTH - MarketBeat

Mar 19, 2025
pulisher
Mar 19, 2025

FY2025 Earnings Forecast for DNTH Issued By Lifesci Capital - MarketBeat

Mar 19, 2025
pulisher
Mar 18, 2025

Wedbush Equities Analysts Reduce Earnings Estimates for DNTH - MarketBeat

Mar 18, 2025
pulisher
Mar 17, 2025

FY2025 EPS Estimates for DNTH Raised by Cantor Fitzgerald - Defense World

Mar 17, 2025
pulisher
Mar 17, 2025

HC Wainwright Reaffirms "Buy" Rating for Dianthus Therapeutics (NASDAQ:DNTH) - MarketBeat

Mar 17, 2025
pulisher
Mar 17, 2025

HC Wainwright Issues Optimistic Outlook for DNTH Earnings - Defense World

Mar 17, 2025
pulisher
Mar 16, 2025

Dianthus Therapeutics' (DNTH) Outperform Rating Reiterated at Wedbush - MarketBeat

Mar 16, 2025
pulisher
Mar 16, 2025

Dianthus Therapeutics (NASDAQ:DNTH) Shares Gap DownWhat's Next? - MarketBeat

Mar 16, 2025
pulisher
Mar 16, 2025

Dianthus Therapeutics (DNTH) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Mar 16, 2025
pulisher
Mar 15, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat

Mar 15, 2025
pulisher
Mar 15, 2025

Dianthus Therapeutics (NASDAQ:DNTH) Trading Down 5.5%Here's Why - MarketBeat

Mar 15, 2025
pulisher
Mar 15, 2025

Dianthus Therapeutics (NASDAQ:DNTH) Issues Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat

Mar 15, 2025
pulisher
Mar 15, 2025

Research Analysts Set Expectations for DNTH Q1 Earnings - Defense World

Mar 15, 2025
pulisher
Mar 14, 2025

HC Wainwright Reaffirms Buy Rating for Dianthus Therapeutics (NASDAQ:DNTH) - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

Guggenheim Reaffirms Buy Rating for Dianthus Therapeutics (NASDAQ:DNTH) - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

Wedbush Reaffirms “Outperform” Rating for Dianthus Therapeutics (NASDAQ:DNTH) - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

Dianthus Therapeutics, Inc. (DNTH) Reports Q4 Loss, Misses Revenue Estimates - MSN

Mar 13, 2025
pulisher
Mar 13, 2025

Dianthus Therapeutics' (DNTH) "Buy" Rating Reaffirmed at Guggenheim - MarketBeat

Mar 13, 2025
pulisher
Mar 13, 2025

We're Not Very Worried About Dianthus Therapeutics' (NASDAQ:DNTH) Cash Burn Rate - Yahoo Finance

Mar 13, 2025
pulisher
Mar 13, 2025

Dianthus Therapeutics Full Year 2024 Earnings: Beats Expectations - Yahoo Finance

Mar 13, 2025
pulisher
Mar 13, 2025

Dianthus Therapeutics (DNTH) to Release Quarterly Earnings on Thursday - Defense World

Mar 13, 2025
pulisher
Mar 13, 2025

Dianthus Therapeutics Reports 2024 Financial Results and Clinical Progress - TipRanks

Mar 13, 2025
pulisher
Mar 12, 2025

Stifel maintains Buy rating on Dianthus Therapeutics stock By Investing.com - Investing.com Canada

Mar 12, 2025
pulisher
Mar 12, 2025

Dianthus Therapeutics shares fall as Q4 results miss expectations By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 12, 2025

Dianthus Therapeutics shares fall as Q4 results miss expectations - Investing.com India

Mar 12, 2025
pulisher
Mar 12, 2025

Optimistic Buy Rating for Dianthus Therapeutics Driven by Promising DNTH103 Data and Pipeline Progress - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Dianthus Therapeutics: Strong Financials and Promising Clinical Trials Justify Buy Rating - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Given Consensus Rating of “Buy” by Brokerages - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY 2024 Financial Results - The Manila Times

Mar 11, 2025
pulisher
Mar 11, 2025

Dianthus Therapeutics, Inc. /DE/ SEC 10-K Report - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY 2024 - Bluefield Daily Telegraph

Mar 11, 2025

Dianthus Therapeutics Inc (DNTH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
大文字化:     |  ボリューム (24 時間):